GE HealthCare Technologies Inc. will be attending the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting from June 21-24 at the New Orleans Ernest N. Morial Convention Center. At the event, the company will present its innovative portfolio of theranostics-enabling solutions, including the debut of LesionID™ Pro with automated zero-click pre-processing, an AI-powered tool designed to aid physician decision-making and therapy response monitoring.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.